- Joined
- Dec 17, 2007
- Messages
- 3,714
- Reaction score
- 5,232
Oh, you are right!I believe this is considered a positive trial since it's for "signal finding" (positive if p<0.2)...
Oh, you are right!I believe this is considered a positive trial since it's for "signal finding" (positive if p<0.2)...
No conflict of interest here folks. Love that Ron grin. Ron is the epitome of nice, no question, but the fox in the henhouse is what we have here.
His underlings made hundreds of thousands of dollars a year helping practices bill and fine tune etc. Poorly paid low IQ admins loved the results... Can't fault it. But the total lack of boundaries between ASTRO, ASRT, ACRO and Ron are legend. Gotta tip the hat.
![]()
When you ask friends if they’ll take pictures of you during your talk….. | Ron DiGiaimo
When you ask friends if they’ll take pictures of you during your talk….. haha …. Awesome time meeting and getting to know the incredible ASRT leadership team ASRT Foundation American Society of Radiologic Technologists Revenue Cycle Coding Strategies The Oncology Group RC Billing Regents Health...www.linkedin.com
Literally if that's all I have to do, Ill take that deal. I don't find them particularly taxing.
Does every speciality have something like this (i.e re-cert exams or CME requirement)? If so, I will take this as it is a super easy way to meet that requirement. Between this and tumor board being "CME", I am set!Just like 5 or 6 more weeks until we are done for the year 🙂
The questions seem really lazy this year. I agree that it's not a big deal, but toss it on the pile of crap we do for literally no reason other than money or because some administrator thinks they are helping the world.
Cumulatively, its frustrating.
Yes they all require some form of CME or re-cert exams. Even non medical fields like law have something like this required after the bar. Not something unique to rad onc at all.Does every speciality have something like this (i.e re-cert exams or CME requirement)? If so, I will take this as it is a super easy way to meet that requirement. Between this and tumor board being "CME", I am set!
There's gotta be that happy medium somewhere between MOC/10 year certs and grandfathered 2D-trained boomers who couldn't contour a parotid or a prostate bed correctly to save their lifeAh, I entered medical school as all the lifetime certifications were ending and there were a lot of grumbling from faculty about "MOC" and the cost and the process and...
...I didn't get it. Of course doctors should have lifelong requirements to assess competency and ability to practice. It seemed absurd to question.
To me, I use the memory of the first time I reacted to hearing it questioned as the "starting line" of what I thought medicine was vs what I found it to be.
I thought it was a meritocracy. I thought board certification assessed what it claimed to assess. I thought MOC was well designed and a good idea.
But....George W was president back then, and the iPhone hadn't come out. I was dumb.
Interesting. Irrelevant?
Can't omit if you want to preserve organ unless MSI highHeard there will be abstract at Asco that is positive for the ommision of radiation in rectal cancer.
The bird is spicy today
Protons are a metaverseI remember calling the government relations electee a "proton pusher" and being chastised for it here. Both the chair and vice-chair have interest in proton facilities.
Well, 6(?) months later, ASTRO is "pushing" a proton policy, that I'm sure they'll "relate" to CMS to ensure continued reimbursement for dubious indications.
Can't say I'm shocked.
Heard there will be abstract at Asco that is positive for the ommision of radiation in rectal cancer.
Protons are a metaverse
So you take the new NAPT driven proton model policy plus this paper. Billing resources are behind a very pricey paywall. The scientific content is mostly trash, and the rest you get it on Twitter or other journals.
I work in a highly competitive market without a single proton unit in the entire state.
Why in the world would I give money to ASTRO or the PAC at this point? They are going to need a massive change in priorities to convince me to ever come back.
View attachment 371127
Yes.
Instead of pushing for protons and some APM version (largely drafted/influenced by people that will not be subject to an APM), the LASER focus of ASTRO should be stopping these cuts.
The fact is that if they can get protons paid for they're more than happy to take nominal medicare cuts elsewhere, it'll be a net positive at centers with proton capability.
I trashed ASTRO PAC before it was cool (back when they were trying to kill multi-specialty ownership of linacs including by the RO via killing the stark law in-office ancillary exemption).So you take the new NAPT driven proton model policy plus this paper. Billing resources are behind a very pricey paywall. The scientific content is mostly trash, and the rest you get it on Twitter or other journals.
I work in a highly competitive market without a single proton unit in the entire state.
Why in the world would I give money to ASTRO or the PAC at this point? They are going to need a massive change in priorities to convince me to ever come back.
View attachment 371127
Perfect quote. Proformas-->Protons. Science be damned.Protons are a metaverse
Unlike spacer gels or protons, both of which have lacking (and possibly adverse) data, i think you could at least make a use case for an MR-L with the mri imaging/targeting capability for certain sites (plus much cheaper than a proton unit)So is proton money evil only or do we throw the MRI-L angle in there into the grift stew/hog head cheese?
Im pro tech obviously so im just playing devils advocate. So don’t get me wrong, i have an MRIL angle as well! Having said that, Im very skeptical about Kishan paper/margin isssue. MRIL will have to be held to same standards before justifying costs, even if “cheaper” than protons. NAPT approving proton ASTRO guidelines, no doubt viewray/elekta would be involved in MRIL “guidelines”. If i were buying an MRIL i’d choose Elekta due to superior Tesla magnet and better company, not on the verge of potential bankruptcy/sell off.Unlike spacer gels or protons, both of which have lacking (and possibly adverse) data, i think you could at least make a use case for an MR-L with the mri imaging/targeting capability for certain sites (plus much cheaper than a proton unit)
So is proton money evil only or do we throw the MRI-L angle in there into the grift stew/hog head cheese?
We are in a pickle of sorts.So is proton money evil only or do we throw the MRI-L angle in there into the grift stew/hog head cheese?
We are in a pickle of sorts.
I strongly believe that protons have been oversold since the mid 2000s and their further adoption has been strictly cultural and economic and not based on good science.
But, if a new radonc intervention was developed, which was appreciably better than the standard of care, yet required the type of high capital investment and physics expertise that a community practice isn't gonna have, I would also probably want to crap on it.
If only we were developing pills, and the care model was in general community practice with academic expertise reserved for clinical trial type work.
Back in high school, a friend of mine had a band called “smile in the ice machine”. Similar concept. The meat has to be moved. Plenty of slime in our field. You betcha!Meat on the Machine
I heard that was, ironically, the next album title from Metallica.
![]()
And it won’t be. The best you can hope for is becoming a cog in the academic profit machine under the guise of quality.
I’m post EBM at this point. I don’t care about the science anymore. I only care about job security and putting meat on the machine. If it means endorsing proton or MRIL without the most rigorous of tests fine. You want precedent for this type of behavior? (See literally every other field)
Modality shaming needs to become a thing like fraction shaming, esp given the shameless push by protonistas in ASTRO with this most recent statement being put out.And it won’t be. The best you can hope for is becoming a cog in the academic profit machine under the guise of quality.
I’m post EBM at this point. I don’t care about the science anymore. I only care about job security and putting meat on the machine. If it means endorsing proton or MRIL without the most rigorous of tests fine. You want precedent for this type of behavior? (See literally every other field)
I don’t know about anyone else, but I don’t think this can translate into any REAL changes…
“they can lead image review, specific technical and/or clinical procedures, patient education and follow-up, clinical markup of treatment sites, care coordination, knowledge translation, research, and participate in clinical leadership”
…aren’t they doing that stuff already?
“Limited prescribing” sounds suspiciously like giving patients moisturizer
Seems more like they are trying to dress up the RTT role with a whole load of jibberish to entice more people train as RTTs. The RTTs I know are too bright to fall for this nonsense
I don’t know about anyone else, but I don’t think this can translate into any REAL changes…
“they can lead image review, specific technical and/or clinical procedures, patient education and follow-up, clinical markup of treatment sites, care coordination, knowledge translation, research, and participate in clinical leadership”
…aren’t they doing that stuff already?
“Limited prescribing” sounds suspiciously like giving patients moisturizer
Seems more like they are trying to dress up the RTT role with a whole load of jibberish to entice more people train as RTTs. The RTTs I know are too bright to fall for this nonsense
RO-APM was performative and meant to further consolidate power among the PPS-exempt centers.A 40 percent discount and still not low enough? What do they think RO APM will bring?
APM as proposed by ASTRO was good policy and would have stabilized payments. Medicare’s version was terrible and they weren’t willing to listen to any stakeholders. I don’t know how it gets done, but we need a bundled payment system as fx inevitably go down and Medicare remains revenue neutral while also increasing primary care reimbursement.RO-APM was performative and meant to further consolidate power among the PPS-exempt centers.
It's why the only clinical advisor for CMS was from Anderson.
It's why the GAO report from 2015, showing a half a billion dollars in savings if PPS-exempt status was ended...fell by the wayside in favor of pursuing this boondoggle with a potential savings of only $40 million....but all on the backs of the community.
Do I think there's some nefarious, overarching plot here?
Nah.
But ASTRO is really "it" in terms of American RadOnc professional societies, and it's run mostly by folks from PPS-exempt centers with protons.
No one votes against their own interests.
APM as proposed by ASTRO was good policy and would have stabilized payments. Medicare’s version was terrible and they weren’t willing to listen to any stakeholders. I don’t know how it gets done, but we need a bundled payment system as fx inevitably go down and Medicare remains revenue neutral while also increasing primary care reimbursement.
APM as proposed by ASTRO was good policy and would have stabilized payments. Medicare’s version was terrible and they weren’t willing to listen to any stakeholders. I don’t know how it gets done, but we need a bundled payment system as fx inevitably go down and Medicare remains revenue neutral while also increasing primary care reimbursement.
This really hits the nail on the head. Rad Onc as a field is such a minimal contribution to CMS overall cancer spend. Once CMS gets the authorization to negotiate drug prices (2025, I believe?), then the real cost savings can begin.RO-APM was performative and meant to further consolidate power among the PPS-exempt centers.
It's why the only clinical advisor for CMS was from Anderson.
This really hits the nail on the head. Rad Onc as a field is such a minimal contribution to CMS overall cancer spend. Once CMS gets the authorization to negotiate drug prices (2025, I believe?), then the real cost savings can begin.